Maryland Rosenfeld-Franklin

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

Stacey R. Dillon, Cindy A. Sprecher, Angela Hammond et al. · Nature Immunology · 2004 · 1K citations

Medicine, Dermatology, Immunology +14

Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor

Mark J. Mulvihill, Andrew Cooke, Maryland Rosenfeld-Franklin et al. · Future Medicinal Chemistry · 2009 · 308 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +15

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak et al. · Molecular Cancer Therapeutics · 2010 · 218 citations

Medicine, Oncology, Pharmacology +17

Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors

Elizabeth Buck, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin et al. · Cancer Research · 2008 · 209 citations · Full text

Medicine, Oncology, Pharmacology +17

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling <i>in vitro</i> and inhibits insulin-like growth factor-I receptor–dependent tumor growth <i>in vivo</i>

Qunsheng Ji, Mark J. Mulvihill, Maryland Rosenfeld-Franklin et al. · Molecular Cancer Therapeutics · 2007 · 147 citations · Full text

Medicine, Oncology, Pharmacology +17